Probiotic
            <i>Weissella cibaria</i>
            KY10 derived from digestive tract of healthy shrimp exhibits strong antibacterial effects against
            <i>Vibrio parahaemolyticus</i>
            causing AHPND in shrimp

Kanjan, Pochanart; kimtun, Apisit; Chaimongkol, Saweit; Sakpetch, Phat

doi:10.1111/are.15777

Cited by 4 publications

(1 citation statement)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lim et al [101] successfully explored the antimicrobial activity of W. cibaria, CMU, against oral pathogens, possibly due to acid and hydrogen peroxide. Another strain of W. cibaria, KY10, isolated from shrimp gut, was shown to have bactericidal activity against Vibrio parahaemolyticus T.11 through the mechanism of organic acid release [102]. In another study, Dey et al [103] examined the antibacterial activity of W. confusa DD_A7 isolated from kimchi and found that the DD-A7 strains trigger the oxidative stress to inhibit the growth of extended-spectrum β-lactamase (ESBL)-positive E. coli, which are emerging pathogens.…”

Section: Antimicrobial Potentialmentioning

confidence: 99%

The Weissella Genus: Clinically Treatable Bacteria with Antimicrobial/Probiotic Effects on Inflammation and Cancer

Ahmed

Singh

et al. 2022

Microorganisms

View full text Add to dashboard Cite

Weissella is a genus earlier considered a member of the family Leuconostocaceae, which was reclassified into the family Lactobacillaceae in 1993. Recently, there have been studies emphasizing the probiotic and anti-inflammatory potential of various species of Weissella, of which W. confusa and W. cibaria are the most representative. Other species within this genus include: W. paramesenteroides, W. viridescens, W. halotolerans, W. minor, W. kandleri, W. soli, W. ghanensis, W. hellenica, W. thailandensis, W. fabalis, W. cryptocerci, W. koreensis, W. beninensis, W. fabaria, W. oryzae, W. ceti, W. uvarum, W. bombi, W. sagaensis, W. kimchi, W. muntiaci, W. jogaejeotgali, W. coleopterorum, W. hanii, W. salipiscis, and W. diestrammenae. Weissella confusa, W. paramesenteroides, W. koreensis, and W. cibaria are among the few species that have been isolated from human samples, although the identification of these and other species is possible using metagenomics, as we have shown for inflammatory bowel disease (IBD) and healthy controls. We were able to isolate Weissella in gut-associated bacteria (post 24 h food deprivation and laxatives). Other sources of isolation include fermented food, soil, and skin/gut/saliva of insects/animals. With the potential for hospital and industrial applications, there is a concern about possible infections. Herein, we present the current applications of Weissella on its antimicrobial and anti-inflammatory mechanistic effects, the predisposing factors (e.g., vancomycin) for pathogenicity in humans, and the antimicrobials used in patients. To address the medical concerns, we examined 28 case reports focused on W. confusa and found that 78.5% of infections were bacteremia (of which 7 were fatal; 1 for lack of treatment), 8 were associated with underlying malignancies, and 8 with gastrointestinal procedures/diseases of which 2 were Crohn’s disease patients. In cases of a successful resolution, commonly administered antibiotics included: cephalosporin, ampicillin, piperacillin-tazobactam, and daptomycin. Despite reports of Weissella-related infections, the evolving mechanistic findings suggest that Weissella are clinically treatable bacteria with emerging antimicrobial and probiotic benefits ranging from oral health, skin care, obesity, and inflammatory diseases to cancer.

show abstract

Section: Antimicrobial Potentialmentioning

confidence: 99%